• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[德国官方药品控制实验室在打击假药方面的作用]

[The role of German official medicines control laboratories in combating counterfeit medicines].

作者信息

Wiegard Andrea, Heuermann Matthias

机构信息

Landeszentrum Gesundheit Nordrhein-Westfalen, Von-Stauffenberg-Str. 36, 48151, Münster, Deutschland.

出版信息

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1214-1220. doi: 10.1007/s00103-017-2624-8.

DOI:10.1007/s00103-017-2624-8
PMID:28948293
Abstract

An official medicines control laboratory (OMCL) provides an important contribution to combat counterfeit and illegal medicines. The OMCL supports the competent authorities in controlling the quality of authorised medicinal products in the legal supply chain. For detecting counterfeit medicines in the legal supply chain, a risk-based approach in choice of products is conducted. Furthermore, the OMCL analyses suspicious medicines from the illegal supply chain for any other authority. The chemical analysis of a suspicious sample is needed to identify such a sample as a counterfeit medicine. The analytical results are fundamental for the evaluation of the legal status of the product and for the assessment of it's inherent hazard to public health. The global market of illegal medicines is rapidly changing. Therefore a good national and international working liaison and co-operation between laboratories and authorities is obligatory to protect public health. The OMCL provides important knowledge of new trends in counterfeit and illegal medicines. Hence, it is an essential part in surveillance of medicinal products. The efficient networking enables prompt official interventions. Thus, risks for the public health by substandard medicines were reduced. Beside the chemical analysis, the OMCL can help to raise public awareness about counterfeit and illegal medicines. In Germany, the risk of counterfeit medicines reaching patients through the legal supply chain is still low, but the possibility cannot be ignored.

摘要

官方药品控制实验室(OMCL)对打击假冒和非法药品做出了重要贡献。OMCL支持主管当局对合法供应链中授权药品的质量进行控制。为了在合法供应链中检测假冒药品,在产品选择上采用基于风险的方法。此外,OMCL还为任何其他当局分析来自非法供应链的可疑药品。需要对可疑样品进行化学分析,以确定该样品为假冒药品。分析结果对于评估产品的合法状态以及评估其对公众健康的内在危害至关重要。非法药品的全球市场正在迅速变化。因此,实验室与当局之间良好的国家和国际工作联络与合作对于保护公众健康是必不可少的。OMCL提供有关假冒和非法药品新趋势的重要知识。因此,它是药品监管的重要组成部分。高效的网络连接能够迅速进行官方干预。因此,不合格药品对公众健康的风险得以降低。除了化学分析,OMCL还可以帮助提高公众对假冒和非法药品的认识。在德国,通过合法供应链到达患者手中的假冒药品风险仍然较低,但这种可能性不能被忽视。

相似文献

1
[The role of German official medicines control laboratories in combating counterfeit medicines].[德国官方药品控制实验室在打击假药方面的作用]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1214-1220. doi: 10.1007/s00103-017-2624-8.
2
[European Network of Official Medicines Control Laboratories : International OMCL Working Group Combating Counterfeit and other Illegal Medicines].[欧洲官方药品控制实验室网络:国际药品质量控制实验室工作组打击假冒和其他非法药品]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1221-1227. doi: 10.1007/s00103-017-2625-7.
3
[Falsified medicines in parallel trade].[平行贸易中的假药]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1208-1213. doi: 10.1007/s00103-017-2620-z.
4
[Current cases of falsified medicinal products within the competence of the Federal Institute for Drugs and Medical Devices (BfArM) : Case studies and extent].[联邦药品和医疗器械研究所(BfArM)权限范围内的假药当前案例:案例研究与范围]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1196-1202. doi: 10.1007/s00103-017-2635-5.
5
[Operation Pangea - standing together in combat against international pharmaceutical crime].[泛大陆行动——携手打击国际药品犯罪]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1233-1239. doi: 10.1007/s00103-017-2629-3.
6
[The Herceptin® case : A case of falsification of medicinal products to a greater extent].[赫赛汀®案例:一起大规模药品造假案件]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1203-1207. doi: 10.1007/s00103-017-2622-x.
7
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
8
[The Working Group of Enforcement Officers (WGEO) : The European Network of Drug Regulatory Authorities to Combat Pharmaceutical Crime].[执法官员工作组(WGEO):欧洲打击药品犯罪药品监管当局网络]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1228-1232. doi: 10.1007/s00103-017-2623-9.
9
[Falsified pharmaceutical products : Legislative measures in the European Union and in Germany].[假药:欧盟及德国的立法措施]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1188-1195. doi: 10.1007/s00103-017-2621-y.
10
[Task force for falsified medicines].[假药问题特别工作组]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Nov;60(11):1240-1244. doi: 10.1007/s00103-017-2626-6.